Bio-solution · AP01 · Alternative proteins
Precision-fermentation dairy and egg proteins (whey, casein, ovalbumin) and fungal biomass protein (mycoprotein) instead of a share of antibiotic- and land-intensive animal protein
Replaces
A share of conventional dairy and meat protein — and with it the antibiotics, antiparasitics, fertilizer and pesticide inputs of the animal-feed chain; animal-derived processing ingredients (rennet already covered in FI05)
A share of conventional dairy and meat protein — and with it the antibiotics, antiparasitics, fertilizer and pesticide inputs of the animal-feed chain; animal-derived processing ingredients (rennet already covered in FI05)
→
Scope
Food ingredients (B2B) and consumer foods; precision fermentation in microbial hosts; fungal biomass fermentation
Food ingredients (B2B) and consumer foods; precision fermentation in microbial hosts; fungal biomass fermentation
Suppliers 6
| Remilk | Israel | active |
| Imagindairy | Israel | active |
| Zero Cow Factory | India | active |
| OsomeFood | Singapore | active |
| CellX | China | active |
| Joes Future Food (Nanjing) | China | active |
Route into Russia / EAEU NOVEL
- Regulator
- Rospotrebnadzor / EAEU
- Typical time
- state registration as a new type of food; no fixed term published
- Legal basis
- TR CU 021/2011: novel foods (not previously consumed in the EAEU, incl. from microorganisms, fungi, algae) need state registration; no specific route for cultivated meat
Information, not legal advice — confirm the procedure for your product.
Proof 2 claims
Old process
Conventional animal-based agriculture (dairy, egg, and meat production).
Conventional animal-based agriculture (dairy, egg, and meat production).
→
New practice
Precision fermentation and mycoprotein production.
Precision fermentation and mycoprotein production.
- Displaced at scale?
- no
- Caveats
- Precision fermentation and mycoprotein have not displaced conventional animal protein at a significant commercial scale; the technology is in a nascent stage, facing challenges in scaling production, achieving cost parity with commodity proteins, and navigating regulatory hurdles.
- checked
- 2026-10-06
| Precision fermentation milk's land footprint is estimated to be 94–96% lower than that of cow's milk in the UK. “The results of this study estimate the land footprint of PF milk to be 94–96% lower than that of cow’s milk in the UK.” UK · 2026 · not applicable | peer-reviewed ✓ www.frontiersin.org |
| Precision fermentation proteins currently struggle to compete with commodity protein prices, with most models showing costs exceeding the $5–20/kg target. “Published PF protein models generally show costs exceeding the $5–20/kg target for commodity proteins.” global · 2025 · not applicable | weak (company, news, market research, other) ✓ gfi.org |
Details
Replaces (partial): a share of animal protein and its chemical inputs · Scope: food ingredients and foods · Evidence: high (products), medium (environment at scale)
The chemical problem#
- Animal protein carries the heaviest chemical footprint per kg of protein: most of the world’s antibiotics are used in food animals, and feed crops take fertilizer and pesticides.
- The catalogue’s veterinary, feed and livestock-emissions collections reduce these inputs per animal. Alternative proteins reduce the number of animals needed for the same protein.
- This collection is outside the catalogue’s usual “chemical X → biological Y” frame: the substitution is indirect. Ratings stay Partial.
Product overview#
- Precision fermentation — microbes (yeasts such as Pichia/Komagataella, fungi such as Trichoderma, bacteria) produce a specific animal protein: β-lactoglobulin (whey), caseins, ovalbumin, lactoferrin. The protein is identical to the animal one; the microbe is removed.
- Mycoprotein / fungal biomass — the whole fungal mycelium (e.g. Fusarium venenatum, Neurospora, Aspergillus species) is the food: high protein and fibre, meat-like texture.
- Microbial biomass protein — bacterial or algal single-cell protein for food (gas fermentation for feed is covered in FD06).
Active ingredient / Composition#
- Precision-fermented whey/casein: >90 % target protein after purification; lactose- and cholesterol-free.
- Mycoprotein: ~45 % protein and ~25 % fibre (dry basis), low saturated fat.
Key facts#
| Parameter | Value |
|---|---|
| Market status | Mycoprotein on sale for decades (UK); precision-fermented whey in US products; Israel, Singapore and the USA have approval routes |
| Modelling | Replacing 20 % of per-capita ruminant meat with microbial protein by 2050 was projected to roughly halve deforestation and related emissions |
| Regulation | EU novel-food authorization (EFSA) required; Russia/EAEU: state registration of new food products; GM-host labelling rules differ |
| Cost | Precision-fermented proteins still cost more than dairy protein; mycoprotein is near price parity in some markets |
Advantages#
- No antibiotics, hormones or zoonotic risk in production.
- Much lower land and water use per kg protein; can run on sugar from residues.
- Functionally identical proteins (whey, casein) for cheese, yoghurt and bakery.
- Uses the same fermentation infrastructure as enzymes and vitamins (FI04, I02).
Mode of action#
- A gene for the animal protein is inserted into a microbial host; the host secretes the protein during fermentation; downstream processing purifies it.
- Mycoprotein: continuous fermentation of a filamentous fungus on glucose, then heat treatment (RNA reduction), dewatering and texturizing.
Application#
| Product | Target | Method, timing and specifics |
|---|---|---|
| Dairy-alternative cheese, ice cream, yoghurt | Dairy functionality | Precision-fermented casein/whey in blends with plant fats |
| Bakery, confectionery, sports nutrition | Egg/whey replacement | Precision-fermented ovalbumin or β-lactoglobulin |
| Meat alternatives | Texture, protein | Mycoprotein alone or hybrid with plant protein (see AP02) |
| Food manufacturers | Supply security | Long-term offtake contracts with fermentation producers |
Limitations#
- High capital cost of fermentation capacity; scale-up is the main bottleneck.
- Novel-food approval takes years and differs by country.
- Energy and sugar inputs determine the environmental benefit.
- Consumer acceptance of “lab” or GM-host products varies; mycoprotein can cause rare allergic reactions.
Evidence of displacement — D1: works, adoption not proven#
Verified figures (the number is in the quoted sentence and the sentence is on the source page):
- performance — Precision fermentation milk’s land footprint is estimated to be 94–96% lower than that of cow’s milk in the UK. (UK, 2026; peer-reviewed: frontiersin.org)
- economics — Precision fermentation proteins currently struggle to compete with commodity protein prices, with most models showing costs exceeding the $5–20/kg target. (global, 2025; weak: gfi.org)
Suppliers — real products and services (from the vendor index)#
Active vendors whose own card shows precision-fermented dairy proteins or fungal/mycoprotein foods.
| Company | Region · Country | What the index shows | Card |
|---|---|---|---|
| Remilk | Africa/ME · Israel | precision-fermentation dairy proteins | card |
| Imagindairy | Africa/ME · Israel | precision-fermentation whey and casein | card |
| Zero Cow Factory | Asia · India | precision-fermented casein | card |
| OsomeFood | Asia · Singapore | mycoprotein / plant-based food | card |
| CellX | Asia · China | pivoted from cultivated meat to mycelium food brand Mourish | card |
| Joes Future Food (Nanjing) | Asia · China | hybrid mycoprotein / cultivated-meat products | card |
Government funding signals#
Scanned 2026-10-01 (OpenAIRE + NSF); candidates reviewed by hand.
Signal: Strong. UKRI-BBSRC BB/P020364/1 “Mycoprotein 2.0” (£540 k), Innovate UK 102309 (functional mycoprotein from the Quorn process, £356 k), the BOLE project (IBF 6809/31/2021, alt-meat mycoprotein from industrial side streams, 345 k), plus a stream of UK doctoral awards on Fusarium venenatum strain development and mycoprotein from by-products.
Scientific evidence#
- Teng TS, Chin YL, Chai KF, Chen WN (2021). Fermentation for future food systems. EMBO Reports 22: e52680.
- Finnigan TJA, Wall BT, Wilde PJ, et al. (2019). Mycoprotein: the future of nutritious nonmeat protein, a symposium review. Current Developments in Nutrition 3: nzz021.
- Humpenöder F, Bodirsky BL, Weindl I, et al. (2022). Projected environmental benefits of replacing beef with microbial protein. Nature 605: 90–96.
- Van Boeckel TP, Brower C, Gilbert M, et al. (2015). Global trends in antimicrobial use in food animals. Proceedings of the National Academy of Sciences 112: 5649–5654.
Bioeconomy value#
Fermentation turns sugar into protein without animals, using the same tanks that make enzymes and vitamins. For a supplier agency this is a B2B ingredient line (whey, casein, mycoprotein) for food manufacturers, not a consumer brand play.